Bahl & Gaynor’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,101
Closed -$214K 331
2025
Q3
$214K Sell
5,101
-1,524
-23% -$67K ﹤0.01% 320
2025
Q2
$292K Sell
6,625
-14,090
-68% -$638K ﹤0.01% 309
2025
Q1
$1.04M Sell
20,715
-27,683
-57% -$1.37M 0.01% 240
2024
Q4
$2.08M Sell
48,398
-2,717
-5% -$115K 0.01% 203
2024
Q3
$2M Sell
51,115
-7,282
-12% -$263K 0.01% 210
2024
Q2
$1.88M Sell
58,397
-14,545
-20% -$469K 0.01% 209
2024
Q1
$2.4M Sell
72,942
-37,177
-34% -$1.29M 0.01% 202
2023
Q4
$3.82M Sell
110,119
-447,710
-80% -$15.4M 0.02% 177
2023
Q3
$20.2M Sell
557,829
-21,505
-4% -$798K 0.13% 96
2023
Q2
$21.8M Buy
579,334
+38,921
+7% +$1.57M 0.13% 93
2023
Q1
$25M Buy
540,413
+368
+0.1% +$17.2K 0.13% 85
2022
Q4
$25M Sell
540,045
-6,093
-1% -$277K 0.16% 81
2022
Q3
$23.9M Sell
546,138
-10,041
-2% -$462K 0.16% 79
2022
Q2
$23.6M Buy
556,179
+184,089
+49% +$7.81M 0.16% 79
2022
Q1
$16.2M Sell
372,090
-98,984
-21% -$4.59M 0.12% 88
2021
Q4
$25M Buy
471,074
+3,565
+0.8% +$179K 0.14% 79
2021
Q3
$22.2M Sell
467,509
-5,140
-1% -$255K 0.14% 79
2021
Q2
$21.5M Sell
472,649
-5,752
-1% -$260K 0.13% 79
2021
Q1
$20.5M Sell
478,401
-3,580
-0.7% -$149K 0.13% 80
2020
Q4
$19.9M Sell
481,981
-6,673
-1% -$264K 0.13% 80
2020
Q3
$19M Buy
488,654
+19,111
+4% +$753K 0.14% 77
2020
Q2
$17.1M Buy
469,543
+31,587
+7% +$1.07M 0.13% 81
2020
Q1
$12.8M Buy
437,956
+235,127
+116% +$9.2M 0.11% 86
2019
Q4
$8.55M Buy
202,829
+179,852
+783% +$7.19M 0.06% 117
2019
Q3
$890K Buy
22,977
+379
+2% +$15K 0.01% 279
2019
Q2
$861K Buy
+22,598
New +$822K 0.01% 284

Other funds holding G

Bahl & Gaynor's G Position: Q4 2025 in Review

Bahl & Gaynor sold out of Genpact (G) in Q4 2025, closing a stake of 5,101 shares — an estimated $214K sold.

Bahl & Gaynor first reported a position in G in Q2 2019 and held it in 26 quarters. The position peaked at $25M in Q4 2022. 522 funds tracked by Wall St. Rank hold G as of Q4 2025.

  • Bahl & Gaynor reported no remaining Genpact position as of Q4 2025 after selling out during the quarter.
  • Bahl & Gaynor sold 5,101 Genpact shares in Q4 2025, an estimated $214K.
  • Bahl & Gaynor first reported a position in Genpact in Q2 2019 and held it in 26 quarters.
  • Bahl & Gaynor's Genpact position peaked at $25M in Q4 2022.
  • 522 funds tracked by Wall St. Rank held Genpact as of Q4 2025.

Based on Bahl & Gaynor's 13F filing for Q4 2025, filed 12 Feb 2026.